TUMOR-MARKERS AS SEEN FROM THE CLINICAL LABORATORY - PHYSIOLOGICAL, BIOCHEMICAL, AND ANALYTICAL ASPECTS

被引：4

作者：

BORMER, OP

PAUS, E

NUSTAD, K

机构：

[1] Central Laboratory, The Norwegian Radium Hospital, N-0310, Oslo

来源：

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 1991年 / 51卷

关键词：

TUMOR MARKERS; CEA; IMMUNOASSAY SPECIFICITY; INTERFERENCE;

D O I：

10.3109/00365519109107721

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：12 / 20

页数：9

共 29 条

[1] EPITOPE GROUP SPECIFICITY OF 6 IMMUNOASSAYS FOR CARCINOEMBRYONIC ANTIGEN [J].

BORMER, OP ;

THRANESTEEN, K .

TUMOR BIOLOGY, 1991, 12 (01) :9-15

[2] INTERFERENCE OF COMPLEMENT WITH THE BINDING OF CARCINOEMBRYONIC ANTIGEN TO SOLID-PHASE MONOCLONAL-ANTIBODIES [J].

BORMER, OP .

JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 121 (01) :85-93

[3]

BORMER OP, 1991, CLIN CHEM, V37, P231

[4]

BORMER OP, 1990, J IMMUNOL METHODS, V127, P171

[5]

BOSCATO LM, 1986, CLIN CHEM, V32, P1491

[6] MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER [J].

CATALONA, WJ ;

SMITH, DS ;

RATLIFF, TL ;

DODDS, KM ;

COPLEN, DE ;

YUAN, JJJ ;

PETROS, JA ;

ANDRIOLE, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1156-1161

[7]

COURNOYER D, 1988, CANCER RES, V48, P3153

[8]

EKINS R, 1990, CLIN CHEM, V36, P1245

[9]

GOSLING JP, 1990, CLIN CHEM, V36, P1408

[10]

HAMMARSTROM S, 1989, CANCER RES, V49, P4852

← 1 2 3 →